Why Do Biotechs Love the IRS Today? Washington Companies Just Got $34M in Grants

Luke Timmerman11/2/10Follow @ldtimmerman

Share and Comment

Leave a Comment Order a Reprint E-mail this Story

• Share on Twitter
• Share on Facebook


• Share on Linkedin
• Share on Google
• Submit to Hacker News

(Page 4 of 4)

PhaseRx $488,958

PhenoPath Laboratories $244,479

Poniard Pharmaceuticals $244,479

Presage Biosciences $244,479

Profibrix $244,479

Proteotech $1,167,529

Qwell Pharmaceuticals $244,479

Rarecyte $244,479

Rhine Pharmaceuticals $244,479

Scolr Pharma $251,087

Silere Medical Technology $244,479

Sound Pharmaceuticals $733,435

STB $244,479

Stratos Genomics $244,479

Syntrix Biosystems $939,604

Theraclone Sciences $977,916

Tissue Regeneration Systems $244,479

Trubion Pharmaceuticals $1,222,395

Unigen $488,958

Uptake Medical $244,479

VLST $733,435

VisionGate $359,482

VPDiagnostics $244,479

XL Sci-Tech $185,409

Xori $244,479

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @ldtimmerman